3 Indian Industrial Stocks With Fast Earnings Growth Investors Should Not Ignore

With euro area and UK business surveys pointing to ongoing expansion in key services and manufacturing pockets, investors are again paying attention to companies that can turn top line resilience into earnings growth. That backdrop puts healthy high growth potential stocks in focus. This article highlights three picks from the screener and explains why their earnings profiles and balance sheets may appeal to investors seeking growth with financial discipline.

The stocks covered below are only a starting sample, with the full healthy high growth potential screen surfacing 132 more companies that have similarly compelling earnings and balance sheet stories that are not discussed here. To go straight to the source and identify your own highest conviction ideas, analyze the Healthy high growth potential screener.

Saatvik Green Energy is a solar equipment and services company that manufactures monocrystalline PERC and N-TOPCon photovoltaic modules, supplies solar pumps and delivers end to end EPC, installation and maintenance for residential, commercial and utility scale projects. The business currently earns all of its revenue from manufacturing solar PV modules, generating about ₹41.4b in this segment. This gives it a direct link to the Healthy high growth potential theme through expected earnings growth tied to solar demand. The company has a market cap of roughly ₹53.3b.

Investors looking at Saatvik Green Energy are essentially weighing strong growth expectations against some real pressure points. Forecast earnings growth of about 49% per year and revenue growth around 31% sit on top of a full order book, with several billion rupees of PV module contracts stretching out to 2027. At the same time, Q1 FY2027 results showed a sharp drop in revenue and net income, margins have compressed to 5.9% and expansion is being funded with external debt that is not well covered by operating cash flow. If management can improve profitability and handle that balance sheet risk, the combination of growth, governance reforms and scale potential could look very different to investors than today’s snapshot suggests.

Saatvik Green Energy’s rapid capacity build and full order book raise big questions about how earnings will scale from here. Get the full story in the analyst forecasts for Saatvik Green Energy and see what could shift the risk balance next.

Build your own healthy growth shortlist around Saatvik Green Energy

Saatvik Green Energy and the other two stocks in this article all came from a single screener, but the real edge comes when you create filters that fit your own style. Use our customisable Screener to mix metrics like future growth, balance sheet strength and risks, or jump straight into our curated Investing Ideas for ready made stock shortlists.

Shaily Engineering Plastics is a precision injection moulding specialist that designs and manufactures customised plastic components and finished products for healthcare, consumer and industrial customers in India and abroad. Its strongest link to the Healthy high growth potential theme is its pharmaceutical CDMO work, where it develops and produces complex drug delivery devices such as inhalers, auto injectors and insulin pens alongside specialty packaging, within a broader portfolio that also includes kitchenware, furniture and personal care products. The company generates about ₹10.2b in revenue from customised components of plastic and other materials and has a market cap of roughly ₹152.8b.

Shaily Engineering Plastics sits at the intersection of fast growing healthcare outsourcing and precision engineering, with its drug delivery pens and pharmaceutical CDMO contracts giving it exposure to rising demand for complex, high margin medical devices. Analysts expect strong earnings and revenue growth over the next few years, backed by capacity expansion, automation and a healthy export mix, and recent quarterly results show that earnings momentum and margins are lining up with that story. The catch is that this growth plan leans heavily on uncertain GLP 1 pen uptake, global demand for healthcare plastics and disciplined execution on a larger fixed cost base. This means investors need to decide whether today’s premium valuation fairly reflects that balance of opportunity and risk.

Shaily Engineering Plastics is benefiting from strong healthcare and CDMO momentum, yet its premium price and GLP 1 exposure leave key questions unanswered. Get the full picture in the analyst forecasts for Shaily Engineering Plastics before the story shifts again.

Cemindia Projects is a Mumbai based construction and civil engineering contractor focused on complex infrastructure, with its strongest link to the Healthy high growth potential theme coming from heavy marine and concrete works such as wharves, berths, dry docks, quay walls and mass rapid transport structures. The company generates all of its ₹102,051 million revenue from construction, mostly within India, giving it broad exposure across ports, metros, highways and industrial civil works without over relying on any one specialist line. Cemindia Projects currently has a market cap of about ₹219.0b.

For investors watching India’s infrastructure build out, Cemindia Projects is hard to ignore. The company’s heavy civil and marine concrete expertise sits behind a strong order book. Analysts expect revenue to grow around 20% per year and earnings to almost double over the next few years as margins improve. A forecast ROE near 28% and access to fresh capital for new projects hint at potential value creation if execution stays tight. The catch is that complex long duration projects, high working capital needs and a premium P/E leave little room for serious missteps. That mix of potential and execution risk is exactly what makes a closer look worthwhile.

Growth expectations and a full Cemindia Projects order book are impressive, yet the premium P/E and complex projects hint at a story investors might be misreading. See how the analyst forecasts for Cemindia Projects could reshape your view of the risk reward trade off.

Seeking Alternatives Before Everyone Else?

Fresh stock ideas can move from quiet accumulation to full breakout before most investors even notice. Do not get caught chasing momentum after it is flying. Act now.

This article by Simply Wall St is general in nature. We provide commentary based on historical data
and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your
financial situation. We aim to bring you long-term focused analysis driven by fundamental data.
Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.
Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com